No evidence for an increased risk of MCM following dolutegravir use in pregnancy in a European setting

Researchers from the DOLOMITE‐EPPICC Group have published a pooled analysis of individual-patient data from seven observational studies investigating the safety of dolutegravir use in pregnancy. More information is available here.

Photo by Julie Viken available from Pexels.com